Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001698530-25-000028
Filing Date
2025-03-24
Accepted
2025-03-24 20:34:19
Documents
1
Period of Report
2024-12-19

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1742862852.html 3  
1 FORM 3 wk-form3_1742862852.xml 3 1563
  Complete submission text file 0001698530-25-000028.txt   3025
Mailing Address 2430 N. HALSTED ST. CHICAGO IL 60614
Business Address 2430 N. HALSTED ST. CHICAGO IL 60614 847-673-1700
EXICURE, INC. (Issuer) CIK: 0001698530 (see all company filings)

EIN.: 815333008 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 2430 N. HALSTED ST. CHICAGO IL 60614
Business Address
Kang Min Woo (Reporting) CIK: 0002061793 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39011 | Film No.: 25765499